Thank you for your ongoing work and commitment to deliver the 2022 autumn COVID-19 booster and flu campaign. We achieved 17 million COVID-19 and over 20 million flu vaccines, alongside continued delivery of routine immunisation programmes. Your efforts continue to save lives.

April 12, 2024 - Information on the spring 2024 campaign for eligible individuals.

August 18, 2022 - Information leaflet and sticker for the COVID-19 autumn vaccination programme.

Bookings opened to everyone aged 50 and over to get their Covid-19 booster and flu vaccines just over a week ago. Since then, hundreds of thousands of people have arranged their life-saving jabs quickly and easily online at www.nhs.uk/covidvaccine or through the free 119 phone service.

March 24, 2022 - A booster dose of vaccine against COVID-19 continues to provide robust protection against hospitalisation for older people nearly four months after getting the third dose, new data from the UK's Health Security Agency on Thursday showed.

January 7, 2022 - In June 2021, JCVI issued interim ... protection against COVID-19 through winter 2021 to 2022 and further into 2022. This advice was finalised in September 2021, setting the priority for booster vaccination beginning with the most vulnerable persons in the UK population; specifically ...

March 26, 2023 - Around six months after the start of the autumn booster rollout, the majority of those in the oldest age groups last received a dose of a COVID-19 vaccine three to six months ago now. Adults aged 50 to 54 years are most likely to have received a vaccine in the last three months. Over 9 in 10 people aged 12 years and over in the UK had received one dose of a COVID-19 vaccine, nearly 9 in 10 had received two doses and around 7 in 10 had received three or more doses by the end of August 2022...

Javid says he asked officials to revise previous plans that would exclude under-65s

August 16, 2022 - Moderna jab designed to target original variant and Omicron has been given go-ahead by UK regulator

The NHS made history when Maggie Keenan received the first COVID-19 jab outside of a clinical trial in December 2020. Since then, NHS staff and volunteers have delivered over 118 million vaccinations in total, including 32 million top-up jabs since the booster rollout began in September.

November 24, 2020 - The NHS spring booster campaign has ended, but Covid vaccines are available privately.

April 12, 2024 - You will be given a booster dose of a vaccine made by Pfizer or Moderna and approved in the UK. These vaccines have been updated since the original vaccines and target a different COVID-19 variant. These updated vaccines boost protection well, and give slightly higher levels of antibody against ...

Simple and secure access to a range of healthcare services · Manage appointments at your GP practice

September 28, 2022 - UKHSA warns of lower levels of natural immunity to flu this year and increased coronavirus (COVID-19) circulation.

Find out if you’re eligible to get a COVID-19 vaccination and how to get it.

The lifesaving autumn booster rollout kicks off in care homes in England today, as the NHS COVID-19 vaccination programme moves to the next phase. From Wednesday, around seven million people, including people aged 75 and over, people who are immunosuppressed and health and care workers will be able to book in online or by calling 119. Millions of invitations will be landing on doormats from Wednesday 7 September ...

October 14, 2022 - The Covid booster jab eligibility has been expanded to include 12 million more people

August 12, 2021 - Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited

September 16, 2021 - Published 16 September 2021 Last updated 2 February 2022 + show all updates ... Added links to translated versions of booster vaccination information – those aged 16 and over and those aged 12 and over who are at risk. ... Added links to the large print, braille and audio versions of COVID-19 ...

August 8, 2023 - An autumn COVID-19 booster vaccination will be offered to those at high risk of serious disease and who are therefore most likely to benefit from